| abstract |
The present invention relates to a novel compound having protein kinase inhibiting activity, a stereoisomer or a pharmaceutically acceptable salt thereof. The compound, stereoisomer or pharmaceutically acceptable salt thereof according to the present invention exhibits protein kinase inhibitory activity, thereby effectively preventing or treating protein kinase-associated diseases, such as the cancer, an autoimmune disease, a neurological disease, a metabolic disease, an infection or the like. |